ГИПЕРБАРИЧЕСКАЯ ОКСИГЕНАЦИЯ В ЛЕЧЕНИИ ПОЗДНИХ ПОСТЛУЧЕВЫХ ЦИСТИТОВ
Аннотация
Лучевая терапия (ЛТ) как самостоятельно, так и в комбинации с другими видами терапии широко применяется при лечении онкоурологических и онкогинекологических заболеваний. Несмотря на постоянное техническое совершенствование оборудования и методов проведения ЛТ, частота осложнений такого вида лечения в ранние и отдаленные сроки остается высокой и, как правило, требуется сложное и длительное лечение. Одним из ведущих патогенетических механизмов развития данных осложнений является повреждение эндотелия сосудов и, как следствие, снижение кровоснабжения и оксигенации тканей органов таза. Одним из наиболее частых осложнений радиотерапии является постлучевой цистит. Среди различных методов лечения постлучевого геморрагического цистита гипербарическая оксигенация показала хорошие результаты, особенно в тех случаях, когда стандартные методы лечения оказывались неэффективными.
Об авторах
О. Б. Лоран
Кафедра урологии и хирургической андрологии ГОУ ДПО РМАПО, Москва
Россия
Россия
Л. А. Синякова
Кафедра урологии и хирургической андрологии ГОУ ДПО РМАПО, Москва
Россия
Россия
А. А. Митрохин
Кафедра урологии и хирургической андрологии ГОУ ДПО РМАПО, Москва
Россия
Россия
А. М. Плесовский
Кафедра урологии и хирургической андрологии ГОУ ДПО РМАПО, Москва
Россия
Россия
Список литературы
1. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:134.
2. Perez C.A., Breaux S., Bedwinek J.M. et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer 1984;54:235-46.
3. Lanciano R.M., Martz K., Montana G.S. et al. Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell Cancer of the uterine cervix. A patterns of care study. Cancer 1992;69:2124-30.
4. Perez C.A., Grigsby P.W., Lockett M.A. et al. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 1999;44(4):855-66.
5. Montana G.S., Fowler W.C. Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications. Int J Radiat Oncol Biol Phys 1989;16(1):95-100.
6. Eifel P.J., Levenback C., Wharton J.T. et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1995;32(5):1289-300.
7. Loqsdon M.D., Eifel P.J. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999;43(4):763-75.
8. Lips I.M., Dehnad H., van Gils C.H. et al. High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients. Radiat Oncol 2008;3:15.
9. Dearnaley D.P., Khoo V.S., Norman A.R. et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999;353:267-72.
10. Peeters S.T., Heemsbergen W.D., vanPutten W.L. et al. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 2005;61(4):1019-34.
11. Boersma L.J., van den Brink M.,Bruce A.M. et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998;41(1):83-92.
12. Beard C.J., Lamb C., Buswell L. et al. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 1998;41(2):257-62.
13. Fukunaga-Johnson N., Sandler H.M.,McLaughlin P.W. et al. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 1997;38(2):311-7.
14. Crook J., Esche B., Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective. Urology 1996;47(3):387-94.
15. Michalski J.M., Winter K., Purdy J.A. et al. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys 2005;62(3):706-13.
16. Бардычев М.С. Лучевые повреждения. В кн.: Лучевая терапия злокачественных опухолей. Под ред. Е.С. Киселевой. М., 1996. с. 437-57.
17. Antonakopoulos G.N., Hicks R.M.,Berry R.J. The subcellular basis of damage to the human urinary bladder induced by irradiation. J Pathol 1984;143(2):103-16.
18. Corcos J., Schick E. Textbook of the neurogenic bladder. 2nd ed. London: Informa healthcare, 2008. p. 252-3.
19. Dwyer P.L. Atlas of urogynecological endoscopy. London: Informa healthcare, 2007. p. 77-9.
20. Robertson P.W., Hart B.B. Assessment of tissue oxygenation. Respir Care Clin North Am 1999;5(2):221-63.
21. Матье Д. Гипербарическая медицина: практическое руководство. Пер. с англ. М.: Бином. Лаборатория знаний, 2009.
22. Marx R.E., Ehler W.J., Tayapongsak P.,Pierce L.W. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg 1990;160(5):519-24.
23. Capelli-Schellpfeffer M., Gerber G.S. The use of hyperbaric oxygen in urology. J Urol 1999;162:647-54.
24. Corman J.M., McClure R.D.,Pritchett T.R. et al. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 2003;169(6):2200-2.
25. Chong K.T., Hampson N.B., Corman J.M. Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. Urology 2005;65(4):645-53.
26. Bevers R.F., Bakker D.J., Kurth K.H. Hyperbaric oxygen treatment for hemorrhagic radiation cystitis. Lancet 1995;346(8978):803-5.
27. Mayer R., Klemen H., Quehenberger F. et al. Hyperbaric oxygen -an effective tool to treat radiation morbidity in prostate cancer. Radiother Oncol 2001;61(2):151-6.
28. Mathews R., Rajan N., Josefson L. et al. Hyperbaric oxygen therapy for radiation induced hemorrhagic cystitis. J Urol 1999;161(2):435-7.
29. Lee H.C., Liu C.S., Chiao C., Lin S.N. Hyperbaric oxygen therapy in hemorrhagic radiation cystitis: a report of 20 cases. Undersea Hyperb Med 1994;21(3):321-7.
30. Weiss J.P., Mattei D.M., Neville E.C.,Hanno P.M. Primary treatment of radiationinduced hemorrhagic cystitis with hyperbaric oxygen: 10-year experience. J Urol 1994;151(6):1514-7.
31. Nakada T., Yamaguchi T., Sasagawa I. et al. Successful hyperbaric oxygenation for radiation cystitis due to excessive irradiation to uterus cancer. Eur Urol 1992;22(4):294-7.
32. Rijkmans B.G., Bakker D.J.,Dabhoiwala N.F., Kurth K.H. Successful treatment of radiation cystitis with hyperbaric oxygen. Eur Urol 1989;16(5):354-6.
33. Suzuki K., Kurokawa K., Suzuki T. et al. Successful treatment of radiation cystitis with hyperbaric oxygen therapy: resolution of bleeding event and changes of histopathologocal findings of the bladder mucosa. Int Urol Nephrol 1998;30(3):267-71.
34. Bui Q.C., Lieber M., Withers H.R. et al. The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects. Int J Radiat Oncol Biol Phys 2004;60(3):871-8. 35. Del Pizzo J.J., Chew B.H., Jacobs S.C.,
35. Sklar G.N. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen: long-term follow-up. J Urol 1998;160(3):731-3.
36. Neheman A., Nativ O., Moskovitz B. et al. Hyperbaric oxygen therapy for radiationinduced hemorrhagic cystitis. BJU Int 2005;96(1):107-9.
37. Fink D., Chetty N., Lehm J.P. et al. Hyperbaric oxygen therapy for delayed radiation injuries in gynecological cancers. Int J Gynecol Cancer 2006;16(2):638-42.
38. Miyazato T., Yusa T., Onaga T. et al. Hyperbaric oxygen therapy for radiationinduced hemorrhagic cystitis. Nippon Hinyokika Gakkai Zasshi 1998;89(5):552-6.
39. Yoshida T., Kawashima A., Ujike T. et al. Hyperbaric oxygen therapy for radiationinduced hemorrhagic cystitis. Int J Urol 2008;15(7):639-41.
40. Safra T., Gutman G., Fishlev G. et al. Improved quality of life with hyperbaric oxygen therapy in patients with persistent pelvic radiation-induced toxicity. Clin Oncol 2008;20(4):284-7.
41. Hendricks D.M. Dose response for hyperbaric oxygen treatment of radiation cystitis. Undersea Hyperb Med 2000;21:39-10.
42. Feldmeier J.J, Carl U., Hartmann K.,Sminia P. Hyperbaric oxygen: does it promote growth or recurrence of malignancy? Undersea Hyperb Med 2003;30(1):1-18.
43. Chong K.T., Hampson N.B.,Bostwick D.G. et al. Hyperbaric oxygen does not accelerate latent in vivo prostate cancer: implications for the treatment of radiationinduced hemorrhagic cystitis. BJU Int 2004;94(9):1275-8.
Для цитирования:
Лоран О.Б., Синякова Л.А., Митрохин А.А., Плесовский А.М. ГИПЕРБАРИЧЕСКАЯ ОКСИГЕНАЦИЯ В ЛЕЧЕНИИ ПОЗДНИХ ПОСТЛУЧЕВЫХ ЦИСТИТОВ. Онкоурология. 2010;6(2):73-77. https://doi.org/10.17650/1726-9776-2010-6-2-73-77
For citation:
Loran O.B., Sinyakova L.A., Mitrokhin A.A., Plesovsky A.M. HYPERBARIC OXYGENATION IN THE TREATMENT OF LATE POSTRADIATION CYSTITIS. Cancer Urology. 2010;6(2):73-77. (In Russ.) https://doi.org/10.17650/1726-9776-2010-6-2-73-77
Просмотров: 347
Послать статью по эл. почте 
